
NY-ESO 1 155-163, QLSLLMWIT
Description
About NY-ESO 1 155-163, QLSLLMWIT
The Human Cancer/testis antigen (NY-ESO) 1 Peptide (IEDB: 167652) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Cancer/testis antigen (NY-ESO) Peptide, H-QLSLLMWIT-OH (Uniprot: P78358 aa: 155-163) from JPT is produced under strict quality control and quality management.
NY-ESO 1 155-163, QLSLLMWIT - Specifications
- Peptide sequence: H-QLSLLMWIT-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Melanoma, Hepatocellular carcinoma, Breast cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for NY-ESO 1 155-163, QLSLLMWIT
References:
Read References with JPT’s Antigen Peptides
NY-ESO 1 155-163, QLSLLMWIT has been described in:
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes., J Exp Med, 1998 (PMID: 9432985)
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma., Immunity, 2021 (PMID: 34270940)
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron., Cell, 2022 (PMID: 35139340)
Documentation
Documentation for NY-ESO 1 155-163, QLSLLMWIT
Properties
Properties of NY-ESO 1 155-163, QLSLLMWIT
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Breast cancer, Hepatocellular carcinoma, Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Cancer/testis antigen (NY-ESO) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to NY-ESO 1 155-163, QLSLLMWIT
Information | Values |
---|---|
Sequence: | H-QLSLLMWIT-OH |
Specifications: | 9mer peptide as TFA salt |